SILEXION THERAPEUTICS CORP Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number
SILEXION THERAPEUTICS CORP (SLXN) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number of 4.90 thousand shares as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber · last filed 2026-08-14
- 2026-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 4.90K shares.
- 2026-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 4.90K shares; Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number as first filed 49.00K shares.
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 627.00 shares; Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number as first filed 6.26K shares.
- 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 6.27K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number as first filed |
|---|---|---|
| 2026-06-30 | 4.90K shares 10-Q · filed 2026-08-14 | |
| 2026-03-31 | 4.90K shares S-1/A · filed 2026-08-10 | 49.00K shares 10-Q · filed 2026-05-15 |
| 2025-12-31 | 627.00 shares 10-Q · filed 2026-08-14 | 6.26K shares 10-Q · filed 2026-05-15 |
| 2025-09-30 | 6.27K shares 10-Q · filed 2025-11-12 | |
| 2025-06-30 | 6.27K shares 10-Q · filed 2025-08-12 | |
| 2025-03-31 | 94.04K shares 10-Q · filed 2025-05-13 | |
| 2024-12-31 | 1.61K shares 10-Q · filed 2025-11-12 | 24.10K shares 10-Q · filed 2025-05-13 |
| 2024-09-30 | 236.78K shares 10-Q · filed 2024-11-14 | |
| 2024-06-30 | 59.75K shares 10-Q · filed 2024-08-29 | |
| 2024-01-01 | 121.81K shares 10-Q · filed 2024-08-29 | |
| 2023-12-31 | 485.15K shares 10-Q · filed 2024-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |